{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:14:07Z","timestamp":1740460447503,"version":"3.37.3"},"reference-count":37,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,10,26]]},"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1183\/13993003.02008-2022","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T16:35:23Z","timestamp":1671035723000},"page":"2202008","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of two specific transcriptomic clusters of COVID-19 acute respiratory distress syndrome patients with different immune profiles and different outcomes"],"prefix":"10.1183","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0207-9483","authenticated-orcid":false,"given":"Yuichiro","family":"Shindo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S.","family":"Dela Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"2024102103092085000_61.1.2202008.1","doi-asserted-by":"crossref","first-page":"154021","DOI":"10.1016\/j.jcrc.2022.154021","article-title":"Clinical characteristics, respiratory management, and determinants of oxygenation in COVID-19 ARDS: a prospective cohort study","volume":"71","author":"Estenssoro","year":"2022","journal-title":"J Crit Care"},{"key":"2024102103092085000_61.1.2202008.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.21907"},{"key":"2024102103092085000_61.1.2202008.3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40560-021-00528-w","article-title":"The discovery of biological subphenotypes in ARDS: a novel approach to targeted medicine?","volume":"9","author":"Wildi","year":"2021","journal-title":"J Intensive Care"},{"key":"2024102103092085000_61.1.2202008.4","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2778-x"},{"key":"2024102103092085000_61.1.2202008.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1608077"},{"key":"2024102103092085000_61.1.2202008.6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102103092085000_61.1.2202008.7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211090"},{"key":"2024102103092085000_61.1.2202008.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201603-0645OC"},{"key":"2024102103092085000_61.1.2202008.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209719"},{"key":"2024102103092085000_61.1.2202008.10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02725-2021"},{"key":"2024102103092085000_61.1.2202008.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0602-4"},{"key":"2024102103092085000_61.1.2202008.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25030-7"},{"key":"2024102103092085000_61.1.2202008.13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"2024102103092085000_61.1.2202008.14","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200652"},{"key":"2024102103092085000_61.1.2202008.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.04.013"},{"key":"2024102103092085000_61.1.2202008.16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2024102103092085000_61.1.2202008.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02384-2020"},{"key":"2024102103092085000_61.1.2202008.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04165-2020"},{"key":"2024102103092085000_61.1.2202008.19","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"Wendisch","year":"2021","journal-title":"Cell"},{"key":"2024102103092085000_61.1.2202008.20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00459-2022"},{"key":"2024102103092085000_61.1.2202008.21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cels.2020.05.012","article-title":"Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection","volume":"11","author":"Messner","year":"2020","journal-title":"Cell Syst"},{"key":"2024102103092085000_61.1.2202008.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"2024102103092085000_61.1.2202008.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01499-z"},{"key":"2024102103092085000_61.1.2202008.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100433"},{"key":"2024102103092085000_61.1.2202008.25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024102103092085000_61.1.2202008.26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S2213-2600(21)00494-X","article-title":"Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial","volume":"10","author":"Temesgen","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024102103092085000_61.1.2202008.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105911"},{"key":"2024102103092085000_61.1.2202008.28","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00592-2022"},{"key":"2024102103092085000_61.1.2202008.29","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc5367"},{"key":"2024102103092085000_61.1.2202008.30","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2031994"},{"key":"2024102103092085000_61.1.2202008.31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.789735"},{"key":"2024102103092085000_61.1.2202008.32","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.59534"},{"key":"2024102103092085000_61.1.2202008.33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111315118"},{"key":"2024102103092085000_61.1.2202008.34","doi-asserted-by":"crossref","first-page":"916411","DOI":"10.3389\/fimmu.2022.916411","article-title":"The dynamic role of FOXP3+ Tregs and their potential therapeutic applications during SARS-CoV-2 infection","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"2024102103092085000_61.1.2202008.35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00487"},{"key":"2024102103092085000_61.1.2202008.36","doi-asserted-by":"publisher","DOI":"10.1038\/nri3552"},{"key":"2024102103092085000_61.1.2202008.37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2020.12.002","article-title":"PD-1-expressing SARS-CoV-2-specific CD8+ T cells are not exhausted, but functional in patients with COVID-19","volume":"54","author":"Rha","year":"2021","journal-title":"Immunity"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02008-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:12:12Z","timestamp":1740377532000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02008-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,27]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1183\/13993003.02008-2022"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02008-2022","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"type":"print","value":"0903-1936"},{"type":"electronic","value":"1399-3003"}],"subject":[],"published":{"date-parts":[[2022,12,14]]}}}